Skip to main content
Anthony Visco

Anthony Visco

🇺🇸 United States

Training and career​

  • Current position Professor of obstetrics and gynecology, Duke University12
  • Medical school SUNY Upstate Medical University (MD)3
  • Residency Obstetrics and gynecology, Strong Memorial Hospital, New York3
  • Fellowship Urogynecology, Duke University Medical Center3
  • Leadership Division chief, urogynecology and reconstructive pelvic surgery, Duke University12
  • Leadership President, American Urogynecologic Society (2013)3

Known for​

  • CARE trial reduction-urodynamics analysis (2008). Visco led an analysis of prolapse-reduction urodynamics in stress-continent women undergoing sacrocolpopexy in the CARE trial.4
  • Robotic versus abdominal sacrocolpopexy outcomes (2008). Visco coauthored an early cohort comparison of short-term anatomic outcomes after robotic and open abdominal sacrocolpopexy.5
  • ABC urgency-incontinence trial (2012). Visco led a randomized comparison of oral anticholinergic therapy and 100-unit onabotulinumtoxinA injection for urgency urinary incontinence.6

Contributions​

Visco's cited work covers pelvic organ prolapse repair, including sacrospinous hysteropexy trials, mesh weight and discharge after sacrocolpopexy, and genital hiatus size after vaginal vault suspension.7891011

Cited on WARWIKI

7 publications with Anthony Visco as a listed author are cited on WARWIKI, ordered by the number of pages that cite them. Papers whose author list is shortened to "et al." before this name are not included.

  1. Nager CW, Visco AG, Richter HE, et al. Sacrospinous hysteropexy with mesh vs vaginal hysterectomy for treatment of uterovaginal prolapse: 10-year results of a randomized clinical trial. JAMA Surg. 2026;161(8):764-774. doi
    Cited on: Apical Prolapse · POP Overview
  2. Giugale LE, Hansbarger MM, Askew AL, Visco AG, Shepherd JP, Bradley MS. Assessing pelvic organ prolapse recurrence after minimally invasive sacrocolpopexy: does mesh weight matter? Int Urogynecol J. 2021;32(8):2195-2201. doi
    Cited on: Sacrocolpopexy
  3. Nager CW, Visco AG, Richter HE, et al. Effect of sacrospinous hysteropexy with graft vs vaginal hysterectomy with uterosacral ligament suspension on treatment failure in women with uterovaginal prolapse: 5-year results of a randomized clinical trial. Am J Obstet Gynecol. 2021;225(2):153.e1-153.e31. doi
    Cited on: Sacrospinous Hysteropexy
  4. Askew AL, Visco AG, Weidner AC, Truong T, Siddiqui NY, Bradley MS. Does mesh weight affect time to failure after robotic-assisted laparoscopic sacrocolpopexy? Female Pelvic Med Reconstr Surg. 2020;26(9):536-540. doi
    Cited on: Sacrocolpopexy
  5. Kisby CK, Polin MR, Visco AG, Siddiqui NY. Same-day discharge after robotic-assisted sacrocolpopexy. Female Pelvic Med Reconstr Surg. 2019;25(5):337-341. doi
    Cited on: Sacrocolpopexy
  6. Vaughan MH, Siddiqui NY, Newcomb LK, Weidner AC, Kawasaki A, Visco AG, Bradley MS. Surgical alteration of genital hiatus size and anatomic failure after vaginal vault suspension. Obstet Gynecol. 2018;131(6):1137-1144. doi
    Cited on: Perineorrhaphy
  7. Amundsen CL, Visco AG, Ruiz H, Webster GD. Outcome in 104 pubovaginal slings using freeze-dried allograft fascia lata from a single tissue bank. Urology. 2000;56(6 Suppl 1):2-8. doi
    Cited on: Tutoplast-Processed Allografts

Footnotes​

  1. WRHR Mentors. Duke Department of Obstetrics and Gynecology. Accessed October 2026. ↩ ↩2

  2. Anthony Visco, MD. Duke Department of Obstetrics and Gynecology. Accessed October 2026. ↩ ↩2

  3. Anthony G. Visco, MD. Duke Health. Accessed October 2026. ↩ ↩2 ↩3 ↩4

  4. Visco AG, Brubaker L, Nygaard I, et al. "The role of preoperative urodynamic testing in stress-continent women undergoing sacrocolpopexy: the Colpopexy and Urinary Reduction Efforts (CARE) randomized surgical trial." Int Urogynecol J. 2008;19(5):607–614. doi:10.1007/s00192-007-0498-2 ↩

  5. Geller EJ, Siddiqui NY, Wu JM, et al. "Short-Term Outcomes of Robotic Sacrocolpopexy Compared With Abdominal Sacrocolpopexy." 2008;112(6):1201–1206. doi:10.1097/aog.0b013e31818ce394 ↩

  6. Visco AG, Brubaker L, Richter HE, et al. "Anticholinergic Therapy vs. OnabotulinumtoxinA for Urgency Urinary Incontinence." N Engl J Med. 2012;367(19):1803–1813. doi:10.1056/nejmoa1208872 ↩

  7. Nager CW, Visco AG, Richter HE, et al. Sacrospinous hysteropexy with mesh vs vaginal hysterectomy for treatment of uterovaginal prolapse: 10-year results of a randomized clinical trial. JAMA Surg. 2026;161(8):764-774. doi:10.1001/jamasurg.2026.2263 ↩

  8. Askew AL, Visco AG, Weidner AC, Truong T, Siddiqui NY, Bradley MS. Does mesh weight affect time to failure after robotic-assisted laparoscopic sacrocolpopexy? Female Pelvic Med Reconstr Surg. 2020;26(9):536-540. doi:10.1097/spv.0000000000000632 ↩

  9. Giugale LE, Hansbarger MM, Askew AL, Visco AG, Shepherd JP, Bradley MS. Assessing pelvic organ prolapse recurrence after minimally invasive sacrocolpopexy: does mesh weight matter? Int Urogynecol J. 2021;32(8):2195-2201. doi:10.1007/s00192-021-04681-6 ↩

  10. Kisby CK, Polin MR, Visco AG, Siddiqui NY. Same-day discharge after robotic-assisted sacrocolpopexy. Female Pelvic Med Reconstr Surg. 2019;25(5):337-341. doi:10.1097/spv.0000000000000573 ↩

  11. Nager CW, Visco AG, Richter HE, et al. Effect of sacrospinous hysteropexy with graft vs vaginal hysterectomy with uterosacral ligament suspension on treatment failure in women with uterovaginal prolapse: 5-year results of a randomized clinical trial. Am J Obstet Gynecol. 2021;225(2):153.e1-153.e31. doi:10.1016/j.ajog.2021.03.012 ↩